Skip to main content
Top
Published in: Surgery Today 7/2017

01-07-2017 | Original Article

Ratio of C-reactive protein to albumin is a prognostic factor for operable non-small-cell lung cancer in elderly patients

Authors: Takuro Miyazaki, Naoya Yamasaki, Tomoshi Tsuchiya, Keitaro Matsumoto, Masaki Kunizaki, Ryotaro Kamohara, Go Hatachi, Ryoichiro Doi, Tomohiro Obata, Takeshi Nagayasu

Published in: Surgery Today | Issue 7/2017

Login to get access

Abstract

Purpose

The aim of this retrospective study was to evaluate inflammation-based scoring as a prognostic factor for operable non-small-cell lung cancer (NSCLC) in elderly patients.

Methods

We collected preoperative data from 108 patients aged above 80 years with NSCLC. Inflammation-based scoring systems, including the C-reactive protein to albumin ratio (CAR) and the Glasgow prognostic score (GPS), as well as other clinicopathological factors, were evaluated as potential prognostic factors.

Results

The median patient age was 82 (range 80–93) years and the 5-year overall and disease-specific survival rates were 49.7 and 73.9%, respectively. The cut-off value for CAR was calculated using a receiver operator characteristics analysis and patients were dichotomized accordingly. Patients with a low CAR had significantly higher overall survival than those with a high CAR (<0.028; 65.2% vs. ≥0.028; 31.0%, respectively; p < 0.01). In univariate analysis, female gender, a low Charlson comorbidity index of 0 or 1 and a low CAR were significantly identified in overall survival. On multivariate analysis, a low CAR (p = 0.03, hazard ratio: 2.13, 95% confidence interval 1.074–4.295) was identified as a significant prognostic factor.

Conclusions

The preoperative CAR is a useful predictor of overall survival and could be a simple prognostic tool to help identify resectable NSCLC in elderly patients.
Literature
1.
2.
go back to reference Muraoka M, Oka T, Akamine S, Tagawa T, Sasaki N, Ikuta Y, et al. Surgical treatment for lung cancer in octogenarians. Surg Today. 2005;35:725–31.CrossRefPubMed Muraoka M, Oka T, Akamine S, Tagawa T, Sasaki N, Ikuta Y, et al. Surgical treatment for lung cancer in octogenarians. Surg Today. 2005;35:725–31.CrossRefPubMed
3.
go back to reference Endo H, Yamamoto R, Satoh Y, Kuwano H, Nishizawa N. Risk analysis of pulmonary resection for elderly patients with lung cancer. Surg Today. 2013;43:514–20.CrossRef Endo H, Yamamoto R, Satoh Y, Kuwano H, Nishizawa N. Risk analysis of pulmonary resection for elderly patients with lung cancer. Surg Today. 2013;43:514–20.CrossRef
4.
go back to reference Okami J, Higashiyama M, Asamura H, Goya T, Koshiishi Y, Sohara Y, et al. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small-cell lung cancer. Prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol. 2009;4:1247–53.CrossRefPubMed Okami J, Higashiyama M, Asamura H, Goya T, Koshiishi Y, Sohara Y, et al. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small-cell lung cancer. Prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol. 2009;4:1247–53.CrossRefPubMed
5.
go back to reference Mun M, Kohno T. Video-assisted thoracic surgery for clinical stage I lung cancer in octogenarians. Ann Thorac Surg. 2008;85:406–11.CrossRefPubMed Mun M, Kohno T. Video-assisted thoracic surgery for clinical stage I lung cancer in octogenarians. Ann Thorac Surg. 2008;85:406–11.CrossRefPubMed
6.
go back to reference Tanaka F, Yoneda K. Adjuvant therapy following surgery in non-small cell lung cancer (NSCLC). Surg Today. 2016;46:25–37.CrossRefPubMed Tanaka F, Yoneda K. Adjuvant therapy following surgery in non-small cell lung cancer (NSCLC). Surg Today. 2016;46:25–37.CrossRefPubMed
7.
go back to reference Katayama H, Kurokawa Y, Nakamura K, Ito H, Kanemitsu Y, Masuda N, et al. Extended Clavien–Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46:668–85.CrossRefPubMed Katayama H, Kurokawa Y, Nakamura K, Ito H, Kanemitsu Y, Masuda N, et al. Extended Clavien–Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46:668–85.CrossRefPubMed
8.
go back to reference Chang JY, Senan S, Paul MA, Louie AV, Balter P, Groen HJM, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomized trials. Lancet Oncol. 2015;16:630–7.CrossRefPubMedPubMedCentral Chang JY, Senan S, Paul MA, Louie AV, Balter P, Groen HJM, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomized trials. Lancet Oncol. 2015;16:630–7.CrossRefPubMedPubMedCentral
9.
go back to reference Iwata T, Nagato K, Nakajima T, Suzuki H, Yoshida S, Yoshino I. Risk factors predictive of atrial fibrillation after lung cancer surgery. Surg Today. 2016;46:877–86.CrossRefPubMed Iwata T, Nagato K, Nakajima T, Suzuki H, Yoshida S, Yoshino I. Risk factors predictive of atrial fibrillation after lung cancer surgery. Surg Today. 2016;46:877–86.CrossRefPubMed
10.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.CrossRefPubMed
11.
go back to reference Kawashima M, Murakawa T, Shinozaki T, Ichinose J, Hino H, Konoeda C, et al. Significance of the Glasgow prognostic score as a prognostic indicator for lung cancer surgery. Interact CardioVasc Thorac Surg. 2015;21:637–43.CrossRefPubMed Kawashima M, Murakawa T, Shinozaki T, Ichinose J, Hino H, Konoeda C, et al. Significance of the Glasgow prognostic score as a prognostic indicator for lung cancer surgery. Interact CardioVasc Thorac Surg. 2015;21:637–43.CrossRefPubMed
12.
go back to reference Templeton AJ, McNamara MG, Seruga B, Vera-Badillo FR, Aneja P, Ocana A, et al. Prognostic role of neutrophil-to-lymphocyte ration in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:1–11.CrossRef Templeton AJ, McNamara MG, Seruga B, Vera-Badillo FR, Aneja P, Ocana A, et al. Prognostic role of neutrophil-to-lymphocyte ration in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:1–11.CrossRef
14.
go back to reference Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K, et al. The c-reactive protein/albumin ratio, a novel inflammation-based score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol. 2015;22:803–10.CrossRefPubMed Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K, et al. The c-reactive protein/albumin ratio, a novel inflammation-based score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol. 2015;22:803–10.CrossRefPubMed
15.
go back to reference Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Shibuya N, Kubota K. Clinical significance of the c-reactive protein to albumin ratio for survival after surgery for colorectal cancer. Ann Surg Oncol. 2016;23:900–7.CrossRefPubMed Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Shibuya N, Kubota K. Clinical significance of the c-reactive protein to albumin ratio for survival after surgery for colorectal cancer. Ann Surg Oncol. 2016;23:900–7.CrossRefPubMed
16.
go back to reference Xu XL, Yu HQ, Hu W, Song Q, Mao WM. A novel inflammation-based prognostic score, the c-reactive protein/albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma. PLoS One. 2015;10:e0138657.CrossRefPubMedPubMedCentral Xu XL, Yu HQ, Hu W, Song Q, Mao WM. A novel inflammation-based prognostic score, the c-reactive protein/albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma. PLoS One. 2015;10:e0138657.CrossRefPubMedPubMedCentral
17.
go back to reference Kim MH, Ahn JY, Song JE, Choi H, Ann HW, Kim JK, et al. The C-reactive protein/albumin ratio as an independent predictor of mortality in patients with severe sepsis or septic shock treated with early goal-directed therapy. PLoS One. 2015;10:e0132109.CrossRefPubMedPubMedCentral Kim MH, Ahn JY, Song JE, Choi H, Ann HW, Kim JK, et al. The C-reactive protein/albumin ratio as an independent predictor of mortality in patients with severe sepsis or septic shock treated with early goal-directed therapy. PLoS One. 2015;10:e0132109.CrossRefPubMedPubMedCentral
18.
go back to reference Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg. 2007;246:1047–51.CrossRefPubMed Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg. 2007;246:1047–51.CrossRefPubMed
20.
go back to reference Saito H, Noji T, Mkamura K, Tsuchikawa T, Shichinohe T, Hirano S. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma. Surgery. 2016;159:842–51.CrossRefPubMed Saito H, Noji T, Mkamura K, Tsuchikawa T, Shichinohe T, Hirano S. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma. Surgery. 2016;159:842–51.CrossRefPubMed
21.
go back to reference Pinato DJ, Shiner RJ, Seckl MJ, Stebbing J, Sharma R, Mauri FA. Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer. Br J Cancer. 2014;110:1930–5.CrossRefPubMedPubMedCentral Pinato DJ, Shiner RJ, Seckl MJ, Stebbing J, Sharma R, Mauri FA. Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer. Br J Cancer. 2014;110:1930–5.CrossRefPubMedPubMedCentral
22.
go back to reference Hwang EC, Hwang IS, Yu HS, Kim SO, Jung S II, Hwang JE, et al. Utility of inflammation-based prognostic scoring in patients given systemic chemotherapy first-line for advanced inoperable bladder cancer. Jpn J Clin Oncol. 2012;42:955–60.CrossRefPubMed Hwang EC, Hwang IS, Yu HS, Kim SO, Jung S II, Hwang JE, et al. Utility of inflammation-based prognostic scoring in patients given systemic chemotherapy first-line for advanced inoperable bladder cancer. Jpn J Clin Oncol. 2012;42:955–60.CrossRefPubMed
23.
go back to reference Lealdini V, Trufelli DC, Da Silva FBF, Normando SRC, Camargo EW, De Matos LL, et al. Applicability of modified Glasgow prognostic score in the assessment of elderly patients with cancer: a pilot study. J Geriatr Oncol. 2015;6:479–83.CrossRefPubMed Lealdini V, Trufelli DC, Da Silva FBF, Normando SRC, Camargo EW, De Matos LL, et al. Applicability of modified Glasgow prognostic score in the assessment of elderly patients with cancer: a pilot study. J Geriatr Oncol. 2015;6:479–83.CrossRefPubMed
24.
go back to reference McMillan DC. The systemic inflammation-based Glasgow prognostic score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39:534–40.CrossRefPubMed McMillan DC. The systemic inflammation-based Glasgow prognostic score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39:534–40.CrossRefPubMed
26.
go back to reference Miyazaki T, Sakai T, Tsuchiya T, Yamasaki N, Mine M, Shibata Y, et al. Assessment and follow-up of intercostal nerve damage after video-assisted thoracic surgery. Eur J Cardiothorac Surg. 2011;39:1033–9.CrossRefPubMed Miyazaki T, Sakai T, Tsuchiya T, Yamasaki N, Mine M, Shibata Y, et al. Assessment and follow-up of intercostal nerve damage after video-assisted thoracic surgery. Eur J Cardiothorac Surg. 2011;39:1033–9.CrossRefPubMed
Metadata
Title
Ratio of C-reactive protein to albumin is a prognostic factor for operable non-small-cell lung cancer in elderly patients
Authors
Takuro Miyazaki
Naoya Yamasaki
Tomoshi Tsuchiya
Keitaro Matsumoto
Masaki Kunizaki
Ryotaro Kamohara
Go Hatachi
Ryoichiro Doi
Tomohiro Obata
Takeshi Nagayasu
Publication date
01-07-2017
Publisher
Springer Japan
Published in
Surgery Today / Issue 7/2017
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-016-1448-8

Other articles of this Issue 7/2017

Surgery Today 7/2017 Go to the issue